Home
Conditions
Leukemia, B-Cell

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

NCT00898079

Conditions: Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +43 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

View all 192 locations

View Trial Details

Completed

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

NCT01484015

Conditions: Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

NCT01610180

Conditions: Autoimmune Diseases, Autoimmune Thrombocytopenia, Autoimmune Thrombocytopenic Purpura, +32 more
Locations: Department of Hematology, Ospedale San Bortolo Vicenza, Italy

View Trial Details

Completed

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

NCT02226861

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

NCT01445132

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00119392

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia

NCT01609023

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: University General Hospital of Alexandroupolis; Haemotology Alexandroupoli, Greece

General Hospital of Athens Evangelismos; Hematology Athens, Greece

Laiko General Hospital of Athens; A Propedeutical Clinic of Internal Medicine Athens, Greece

Metropolitan Hospital; Hematology Dept Athens, Greece

View Trial Details

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

NCT01246206

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Leukemia, B-Cell

Leukemia, B-Cell trial results

Related conditions